📰 Crossref Funder News
Crossref Funder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Crossref Funder. Real-time updates on events, politics, business and more.
June 5, 2023
Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma Luis... | June 5, 2023
June 15, 2022
Regular use of glucosamine was significantly related with a 16% lower risk of lung cancer and a 12% decreased risk of lung cancer mortality https://bit.ly/3ixJAND